Results 231 to 240 of about 512,141 (378)

Rational Design of a Perovskite‐Type Catalyst for Toluene Oxidation Via Simultaneous Phosphorus Doping and Post‐Synthesis Acidic Etching

open access: yesENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
Phosphorus doping in the perovskite oxide LaCoO3‐δ (LC) results in the formation of LaCo0.97P0.03O3‐δ(LCP3), which is further modified through post‐synthesis acidic etching, yielding LCP3‐A. Phosphorus doping in LCP3‐A enhances its durability, particularly improving long‐term durability and tolerance to H2O and CO2 during toluene oxidation, while acid ...
Li Yang   +6 more
wiley   +1 more source

Human Extravillous Trophoblasts Require SRC-2 for Sustained Viability, Migration, and Invasion. [PDF]

open access: yesCells
Maurya VK   +6 more
europepmc   +1 more source

Spin Resonance Capture ( SRC )

open access: yes
Spin Resonance Capture ( SRC ) is a system, designed and developed to identify and capture the essence of constructs with unknown infinities based on application of virtual limiters and gates.
openaire   +2 more sources

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia   +2 more
wiley   +1 more source

PEAK1 maintains tight junctions in intestinal epithelial cells and resists colitis by inhibiting autophagy-mediated ZO-1 degradation. [PDF]

open access: yesNat Commun
Zhang Z   +12 more
europepmc   +1 more source

Sacubitril/valsartan versus valsartan initiation in patients naïve to renin–angiotensin system inhibitors: Insights from PARAGLIDE‐HF

open access: yesEuropean Journal of Heart Failure, EarlyView.
Changes in N‐terminal pro‐B‐type natriuretic peptide and assessment of clinical endpoints according to prior exposure to renin–angiotensin system inhibitors in the Pre‐specified substudy of Prospective comparison of ARNI with ARB Given following stabiLization In DEcompensated HFpEF (PARAGLIDE‐HF).
Nina Nouhravesh   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy